Related Experiment Video
Updated: Jan 5, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Dynamic Histone H3 Incorporation Fuels Metastatic Progression
Iva Simeonova1, Geneviève Almouzni1
1Chromatin dynamics, Equipe Labellisée Ligue contre le Cancer, Institut Curie 75005, Paris, France; CNRS (French National Center for Scientific Research), Nuclear Dynamics unit UMR3664, Paris, France; Sorbonne Université 75005, Paris, France; PSL Research University, Paris, France.
Abstract:
Treating metastatic cancers is an ongoing challenge in oncology. A recent paper by Gomes and colleagues proposes histone H3 variant dynamics as major regulator of cell fate transition during metastasis and suggests histone chaperones as therapeutic targets for invasive carcinoma.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Histone Variants at the Centromere
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inheritance of Chromatin Structures
Cancer Cell Migration through Invadopodia

